Immunic (IMUX) Other financing activities (2013 - 2019)

Immunic has disclosed Other financing activities across 7 years of filings, most recently posting $188000.0 for Q4 2019.

• Other financing activities for Q4 2019 came in at $188000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2020 was $188000.0 (up 15.34% YoY), and the FY2019 annual result was $270000.0, changed N/A from the prior year.
• Other financing activities came in at $188000.0 for Q4 2019 at Immunic, up from -$25000.0 in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $362000.0 in Q1 2017 to a low of -$302000.0 in Q2 2017.
• The 5-year median for Other financing activities is -$2000.0 (2016), against an average of $33533.3.
• Across the five-year window, Other financing activities jumped 1321.05% in 2015 and slumped 3250.0% in 2017, its largest moves.
• Immunic's Other financing activities stood at -$38000.0 in 2015, then jumped by 94.74% to -$2000.0 in 2016, then plunged by 3250.0% to -$67000.0 in 2017, then soared by 62.69% to -$25000.0 in 2018, then jumped by 852.0% to $188000.0 in 2019.
• The last three Other financing activities figures came in at $188000.0 (Q4 2019), -$25000.0 (Q3 2018), and -$5000.0 (Q2 2018), per Business Quant data.